All In Biotech

Drug Trial Radar · NCT05619783

Extension Study Evaluating The Safety And Tolerability of AMX0035

A Phase IIIb, Open Label Extension Study Evaluating The Safety And Tolerability of AMX0035 Up To 108 Weeks In Adult Participants With Amyotrophic Lateral Sclerosis (ALS) Previously Enrolled In Study A35-004 (PHOENIX)

Last checked: Nov 19, 2026Latest source record: Jan 13, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

352

Actual

Start

Dec 29, 2022

Primary completion

Oct 16, 2024

Study completion Oct 30, 2024

Sponsor

Lead sponsor
Amylyx Pharmaceuticals Inc.Industry
Sponsor type
Industry
First posted
Nov 17, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective is to evaluate the safety and tolerability of AMX0035 over 108 weeks of open label treatment for participants previously enrolled in Study A35-004 (PHOENIX).

Conditions

  • Amyotrophic Lateral Sclerosis

Interventions

  • AMX0035Drug

    Combination of 3 g phenylbutyrate and 1 g taurursodiol

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To assess the Incidence of Treatment-Emergent Adverse Events during treatment with AMX0035Time frame: 108 weeks

Locations

46 sites in 11 countries. Site status is shown where the registry gives one.

  • University Hospitals Leuven

    Leuven, Belgium

  • Hospices Civils de Lyon Hôpital Neurologique Pierre Wertheimer Cellule Mutualisée de Recherche Clinique (CMRC)

    Bron, France

  • Hopital Gabriel Montpied Service de Neurologie

    Clermont-Ferrand, France

  • CHRU de Lille - Hôpital Roger Salengro

    Lille, France

  • CHU de Limoges - Hôpital Dupuytren

    Limoges, France

  • Hôpitaux Universitaires de Marseille Timone

    Marseille, France

  • CHU de Montpellier

    Montpellier, France

  • Gui de Chauliac

    Montpellier, France

  • CHU Nice

    Nice, France

  • Hôpital de la Salpêtrière

    Paris, France

  • Le Centre Hospitalier Régional Universitaire de Tours

    Tours, France

  • Uniklinikum Dresden

    Dresden, Germany

  • Hannover Medical School

    Hanover, Germany

  • Jena University Hospital

    Jena, Germany

  • Medizinische Fakultät Mannheim der Universität Heidelberg

    Mannheim, Germany

  • University Medical Center Rostock

    Rostock, Germany

  • Ulm University Medical Centre

    Ulm, Germany

  • Trinity College Dublin/Beaumont Hospital

    Dublin, Ireland

  • Università degli Studi di Bari Aldo Moro

    Bari, Italy

  • Centro Clinico NEMO

    Milan, Italy

  • IRCCS - Ospedale San Raffaele

    Milan, Italy

  • University of Milan Medical School

    Milan, Italy

  • IRCCS - Istituto Auxologico italiano

    Milan, Italy

  • Azienda Ospedaliero Universitaria Di Modena

    Modena, Italy

  • Università degli Studi della Campania Luigi Vanvitelli

    Naples, Italy

  • University of Padua

    Padova, Italy

  • Università degli Studi di Bari Aldo Moro

    Tricase, Italy

  • University of Torino

    Turin, Italy

  • University Medical Center Utrecht

    Utrecht, Netherlands

  • Centrum Medyczne Linden

    Krakow, Poland

  • City Clinic Warsaw

    Warsaw, Poland

  • Centro Hospitalar Universitário Lisboa-Norte

    Lisbon, Portugal

  • Hospital del Mar

    Barcelona, Spain

  • Hospital Universitari de Bellvitge-IDIBELL

    Barcelona, Spain

  • Hospital Universitario de Basurto

    Bilbao, Spain

  • Hospital San Rafael

    Madrid, Spain

  • Biodonostia Health Research Institute; Hospital Universitario Donostia

    San Sebastián, Spain

  • Hospital Universitario y Politécnico La Fe

    Valencia, Spain

  • Karolinska Institutet

    Stockholm, Sweden

  • Umeå University Hospital

    Umeå, Sweden

Showing 40 of 46 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.